DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global
Anticoagulants Market: Size, Trends & Forecasts (2017-2021)"
report to their offering.
Global Anticoagulants Market: Size, Trends & Forecasts (2017-2021) provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share by treatment, by segment, and by products.
The report also provides analysis of injectable and oral anticoagulants available in the market. Details of Lovenox, Arixtra, Xarelto, Eliquis, Pradaxa and Savaysa has been provided in the report in terms of their global sales.
A brief analysis of the US anticoagulants market has also been provided
in terms of value and sales of top four oral anticoagulant drugs in the
The most commonly prescribed anticoagulant is Warfarin. Newer types of
anticoagulants are also available and are becoming increasingly common.
These include rivaroxaban (Xarelto), dabigatran (Pradaxa), apixaban
(Eliquis), and edoxaban (Savaysa/Lixiana). Warfarin and the newer
alternatives are taken as tablets or capsules. There's also an
anticoagulant called heparin that can be given by injection.
The global anticoagulants market has increased over the years and is expected to grow in the next four years i.e. 2017-2021, particularly due to development of novel oral anticoagulants (NOACs). The global anticoagulants market is supported by various growth drivers such as growing aging population, rising prevalence of coagulant disorders, increasing demand for NOACs, rising awareness about anticoagulants, etc. Yet, the market faces some challenges which are obstructing the growth of the market. Some of the challenges are stringent regulations from regulatory bodies, high cost of oral anticoagulants, major side-effects associated with the drugs, etc.
Furthermore, the report also assesses the key opportunities available in
the market and outline the market dynamics that are and will be
accountable for growth of the industry. Growth of the global
anticoagulants market has also been forecasted for the period 2017-2021,
taking into consideration previous growth outlines, growth drivers and
the existing and forthcoming trends.
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Global Anticoagulants Product Analysis
5. Region/Country Analysis
6. Market Dynamics
7. Competitive Landscape
8. Company Profiling
- Bayer Group
- Boehringher Ingelheim
- Daiichi Sankyo
For more information about this report visit http://www.researchandmarkets.com/research/37hmjp/global